Organovo

Visit Organovo's website (click on the logo)

Organovo logo

Organovo logo

Board members

Taylor J Crouch

Taylor J Crouch

Chief Executive Officer

Craig Kussman

Craig Kussman

Chief Financial Officer

Paul Gallant

Paul Gallant

General Manager

Sharon Collins Presnell

Sharon Collins Presnell

Chief Scientific Officer

Eric Michael David

Eric Michael David

Chief Strategy Officer

Short Description

Created in 2007, Organovo design and create functional human tissues using three-dimensional bioprinting technology. The Organovo goal is to build living human tissues that are proven to function like native tissues. With reproducible 3D tissues that accurately represent human biology, they are enabling ground-breaking therapies by partnering with academic researchers and biopharmaceutical companies.

Organovo Location

Organovo Location

Products

Organovo commercialized its 3D bio-printed tissue (kidney and liver). They also provide services, meaning that they are performing the study for you using their 3D bio-printed organs.

aaa

Noticeable publications

-3D Proximal Tubule Tissues Recapitulate Key Aspects of Renal Physiology to Enable Nephrotoxicity Testing, Front Physiol (2017)

Modeling Compound-Induced Fibrogenesis In Vitro Using Three-Dimensional Bioprinted Human Liver Tissues, Toxicol Sci, 2016

-Bioprinted 3D Primary Liver Tissues Allow Assessment of Organ-Level Response to Clinical Drug Induced Toxicity In Vitro, Plos One, 2016

-Tissue engineering by self-assembly and bio-printing of living cells, Biofabrication, 2010

This is a unique website which will require a more modern browser to work! Please upgrade today!

Social Media Auto Publish Powered By : XYZScripts.com